Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development

G Ranieri, G Gadaleta-Caldarola… - Current medicinal …, 2012 - ingentaconnect.com
Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play …
被引用次数：100 相关文章

Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development

G Ranieri, G Gadaleta-Caldarola… - Current medicinal …, 2012 - pubmed.ncbi.nlm.nih.gov
Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play …

Sorafenib (BAY 43-9006) in hepatoccellular carcinoma patients: from discovery to clinical development.

G Ranieri, G CALDAROLA GADALETA… - CURRENT …, 2012 - ricerca.uniba.it
Angiogenesis and signaling through the RASlRAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERKcascade have been reported to play …

[引用][C] Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

G Ranieri, G Gadaleta-Caldarola, V Goffredo… - Current Medicinal …, 2012 - cir.nii.ac.jp

Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development.

G Ranieri, G Gadaleta-Caldarola… - Current Medicinal …, 2012 - europepmc.org
Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play …

[引用][C] Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development: Targeting Tumor Angiogenesis: An Update

G RANIERI… - Current medicinal …, 2012 - pascal-francis.inist.fr
Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical
Development : Targeting Tumor Angiogenesis: An Update CNRS Inist Pascal-Francis CNRS …
[PDF] academia.edu

[PDF][PDF] Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

G Ranieri, G Gadaleta-Caldarola… - Current Medicinal …, 2012 - academia.edu
Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play …
[PDF] academia.edu

[PDF][PDF] Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

G Ranieri, G Gadaleta-Caldarola… - Current Medicinal …, 2012 - academia.edu
Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play …

[引用][C] Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

G RANIERI, G GADALETA-CALDAROLA… - Current medicinal …, 2012 - Bentham